Rising PSA: Intermittent hormone deprivation as good as continuousPauses in prostate cancer treatment give patients relief from side-effects Targeted agents tackle metastatic melanomaTwo-drug combo looks promising in phase II trial One year of adjuvant trastuzumab best for breast cancer Six months of treatment may be worse and two years is no better MDs debate merits of complementary cancer care ‘Integrative oncology’ gets government funding, but alarms skeptical physicians New report provides valuable information on breast cancer control across Canada TORONTO | Canadian efforts to reduce the burden of breast cancer—the most commonly diagnosed cancer and second leading cause of cancer death among Canadian women— will soon benefit from a new resource. Treanda: new antineoplastic for leukemia, lymphoma Drug indicated for treatment of patients with relapsed indolent B-cell non-Hodgkin lymphoma. CLINICAL PEARLS: Spot that melanoma Beating breast cancer Dr. Alexandra Ginty’s triumph over invasive disease included emerging with a new outlook on life HPV testing set to become primary cervical cancer screen in Ontario ‘Truly progressive’ recommendation is a first in North America Ontario lags in tracking non-melanoma skin cancers Lack of data hampers research, resource allocation, dermatologist says First Previous 43 44 45 46 47 Next Last
